Microfluidic structure, microfluidic device having the same and method of controlling the microfluidic device

    公开(公告)号:US11110454B2

    公开(公告)日:2021-09-07

    申请号:US16115379

    申请日:2018-08-28

    申请人: NEXUS DX, INC.

    发明人: Beom Seok Lee

    IPC分类号: B01L3/00

    摘要: A microfluidic structure in which a plurality of chambers arranged at different positions are connected in parallel and into which a fixed amount of fluid may be efficiently distributed without using a separate driving source, and a microfluidic device having the same. The microfluidic device includes a platform having a center of rotation and including at least one microfluidic structure. The microfluidic structure includes a sample supply chamber configured to accommodate a sample, a plurality of first chambers arranged in a circumferential direction of the platform at different distances from the center of rotation of the platform, and a plurality of siphon channels, each of the siphon channels being connected to a corresponding one of the first chambers.

    Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP

    公开(公告)号:US11016106B2

    公开(公告)日:2021-05-25

    申请号:US15181283

    申请日:2016-06-13

    申请人: Nexus DX, Inc.

    摘要: A specific and sensitive in vitro ELISA assay and diagnostic test kit is disclosed for determining levels of NT-proBNP protein in a variety of bodily fluids, non-limiting examples of which are blood, serum, plasma, urine and the like. The NT-proBNP ELISA assay test employs the sandwich ELISA technique to measure circulating NT-proBNP in human plasma. In order to obtain antibodies with specific binding properties for targeted amino acid sequences within human proBNP, recombinant human proBNP (or rhproBNP) was expressed and purified for use as an immunogen. Polyclonal antibodies (PAb) to specific amino acid sequences were subsequently purified from goat serum by sequential affinity purification. Monoclonal antibodies were raised against specific polypeptides. Recombinant human NT-proBNP (or rhNT-proBNP) was expressed and purified in order to obtain material for use in calibration of a quantitative method for measurement of human NT-proBNP.

    APPARATUS AND METHODS FOR DETECTING ANALYTES
    8.
    发明申请
    APPARATUS AND METHODS FOR DETECTING ANALYTES 有权
    检测分析仪的装置和方法

    公开(公告)号:US20140370617A1

    公开(公告)日:2014-12-18

    申请号:US14164603

    申请日:2014-01-27

    申请人: Nexus DX, Inc.

    IPC分类号: G01N1/28 B01L3/00

    摘要: The present invention provides an apparatus for retaining solid state reagents and/or for processing sample for a diagnostic test, where the apparatus avoids liquid “hang-up” that would otherwise result in loss of sample or fluid volume during sample transfer. The invention further provides diagnostic methods that employ the apparatus, so as to provide sensitive and accurate analyte detection.

    摘要翻译: 本发明提供了一种用于保持固态试剂和/或用于处理用于诊断测试的样品的装置,其中装置避免了在样品转移期间会导致样品损失或液体体积的液体“挂起”。 本发明还提供了使用该装置的诊断方法,以便提供灵敏和准确的分析物检测。

    POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP

    公开(公告)号:US20220099687A1

    公开(公告)日:2022-03-31

    申请号:US17324685

    申请日:2021-05-19

    申请人: NEXUS DX, INC.

    摘要: A specific and sensitive in vitro ELISA assay and diagnostic test kit is disclosed for determining levels of NT-proBNP protein in a variety of bodily fluids, non-limiting examples of which are blood, serum, plasma, urine and the like. The NT-proBNP ELISA assay test employs the sandwich ELISA technique to measure circulating NT-proBNP in human plasma. In order to obtain antibodies with specific binding properties for targeted amino acid sequences within human proBNP, recombinant human proBNP (or rhproBNP) was expressed and purified for use as an immunogen. Polyclonal antibodies (PAb) to specific amino acid sequences were subsequently purified from goat serum by sequential affinity purification. Monoclonal antibodies were raised against specific polypeptides. Recombinant human NT-proBNP (or rhNT-proBNP) was expressed and purified in order to obtain material for use in calibration of a quantitative method for measurement of human NT-proBNP.